Invitrogen s Sean George on the Company s Strategy for Integration | GenomeWeb

In 2003, Sean George, director of business segments for cell biology, made the cover of Invitrogen’s annual report after moving into his position from Molecular Probes, which Invitrogen acquired that August. Today, George has a new position as vice president of diagnostic tools and solutions for Invitrogen and will be responsible for guiding the integration of the firm’s technology with that of Dynal, which Invitrogen this week said it plans to acquire for $386 million in a transaction that is expected to close in April (see article, page 1).

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic analysis of pollutant-tolerant fish, and more.

Researchers have found a rare carbapenem resistance gene on a US pig farm, NBC News reports.

New York officials are considering the use of a familial DNA search to get a lead on a suspect in the strangulation death of a runner.

NIH Director Francis Collins has selected a retired Army major general and cardiologist for the CEO spot at the agency's embattled Clinical Center.